Human Adipose-Derived Stem/Stromal Cells from Children or Adults?
Authors
Abstract:
Discovering a cell type with the highest efficiency and the least side-effects is one of the priorities of scientists active in this field. Of all the cells, mesenchymal stem cells have been and still are of interest to the researchers for use in pre-clinical and clinical studies due to being easily accessible, pluripotency, secretion of numerous growth factors, low risk of immunological rejection, and not having ethical issues for clinical use. Of all mesenchymal cells, human adipose-derived stem/stromal cells (hADSCs) are more safely and easily accessible, produce more growth factors compared to other mesenchymal stem cells, have the ability to differentiate to various cell lines, secrete high levels of angiogenic factor and their feasibility, safety and efficacy have been confirmed. Therefore, in the last decade, it has received more attention from researchers, compared to other cell sources. Since distribution and function of adipose tissue is versatile and changes at any age during the lifetime, it is expected that at different ages, hADSCs also show different functions and abilities. Therefore, it is hypothesized that autologous implantation is not necessarily always the best choice. Autologous transplantation of hADSCs is only the best choice in ages that these cells have the optimum efficacy. If it is determined in what age these cells have the highest efficacy, choosing the type of implantation will be an important factor in achieving the best response to treatment.
similar resources
Differentiation of Mesenchymal Stem Cells Derived From Human Adipose Tissue into Cholinergic-like Cells: In Vitro Study
Introduction: Cholinergic-associated diseases currently constitute a significant cause of neurological and neurodegenerative disabilities. As the drugs are not efficient in improving the suffered tissues, stem cell treatment is considered an effective strategy for substituting the lost cells. Methods: In the current study, we set out to investigate the differentiation properties of human adip...
full textDevelopment of Simple Protocol for Generation of Functionally Active Hepatocyte-like Cells from Human Adipose Tissue-derived Stem Cells
Background and Aims: Human adipose tissue-derived stem cells (hASCs) are considered as an attractive source of regenerative stem cells, mainly because of their higher proliferation rate, more accessibility and hepatocyte like properties as compared to mesenchymal stem cells isolated from other tissues. Numerous studies have described the beneficial use of adipose tissue-derived stem cells for g...
full textComparison of Characteristics of Human Amniotic Membrane and Human Adipose Tissue Derived Mesenchymal Stem Cells
BACKGROUND Mesenchymal stem cells (MSCs) are ideal candidates for treatment of diseases. Amniotic membranes are an inexpensive source of MSCs (AM-MSC) without any donor site morbidity in cell therapy. Adipose tissue derived stem cells (ASCs) are also suitable cells for cell therapy. There is discrepancy in CD271 expression among MSCs from different sources. In this study, the characteristics...
full textCells Derived from the Nervous System or the (the APUD cells) or the Neurosecretory System)
This article has no abstract
full textReprogramming by cytosolic extract of human embryonic stem cells improves dopaminergic differentiation potential of human adipose tissue-derived stem cells
The extract of pluripotent stem cells induces dedifferentiation of somatic cells with restricted plasticity. In this study, we used the extract of human embryonic stem cells (hESC) to dedifferentiate adipose tissue-derived stem cells (ADSCs) and examined the impact of this reprogramming event on dopaminergic differentiation of the cells. For this purpose, cytoplasmic extract of ESCs was prepare...
full textMy Resources
Journal title
volume 5 issue 12
pages 6779- 6780
publication date 2017-12-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023